This means that passive immunization with tau antibodies is actually a viable therapeutic concentrate on and the CSF volume of p-tau262/356 or in the microtubule binding domain (MTBD) can serve as a handy biomarker of tau pathology to monitor tau therapeutics in medical trials.Given that the leading on the internet artwork gallery, we make it easy